✦ LIBER ✦

CE3 THE COSTS OF ADJUVANT CHEMOTHERAPY IN EARLY STAGE BREAST CANCER PATIENTS: COMPARISON OF ATTRIBUTABLE COST AND MICROCOSTING APPROACHES

✍ Scribed by N Oestreicher; DL Veenstra; H Linden; J McCune; SD Ramsey

Book ID: 119593002
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 53 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62085-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost of adjuvant chemotherapy in pat

The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma

✍ Nina Oestreicher; Scott D. Ramsey; Jeannine S. McCune; Hannah M. Linden; David L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND In the U.S., the majority of premenopausal patients with early‐stage breast carcinoma are treated with adjuvant chemotherapy. However, to the authors' knowledge, there have been few formal analyses of adjuvant chemotherapy cost performed to date, especially in premenopaus

The cost-effectiveness of adjuvant chemo

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses

✍ H.E. Campbell; D. Epstein; D. Bloomfield; S. Griffin; A. Manca; J. Yarnold; J. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Predictors of reduced dose intensity in

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

✍ Michelle Shayne; Jeffrey Crawford; David C. Dale; Eva Culakova; Gary H. Lyman; f 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 295 KB

The incidence of symptomatic thromboembo

The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer

✍ Luke Nolan; Angela Darby; Katia Boleti; Peter Simmonds 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Cost-Effectiveness of the 21-Gene Assay

Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer

✍ Paulden, Mike; Franek, Jacob; Pham, Ba’; Bedard, Philippe L.; Trudeau, Maureen; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Role of XRCC3, XRCC1 and XPD single-nucl

Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients

✍ E. Castro, D. Olmos, A. Garcia, J. J. Cruz… 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 326 KB